Anika Therapeutics, Inc. (ANIK) vs Quantum-Si incorporated (QSI)
A side-by-side comparison of Anika Therapeutics, Inc. and Quantum-Si incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIK
Anika Therapeutics, Inc.
$19.17HealthcareDelayed quote: Oct 6, 2026, 2:48 PM EDT
QSI
Quantum-Si incorporated
$1.25HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Total return — ANIK vs QSI
growth of $100 · dividends reinvested · last 6yANIK -43.8% (-9.2%/yr)QSI -87.0% (-28.9%/yr)ANIK compounded faster over this window
ANIK QSI
ANIK vs QSI: by the numbers
- •ANIK is the larger company ($257M vs $246M market cap).
- •Both run net losses; ANIK's is the smaller (-3.14% vs -6138.26% net margin).
Metrics side by side
Valuation
| Metric | ANIK | QSI |
|---|---|---|
| Forward P/E | 18.26 | N/A |
| P/S ratio | 2.13 | 153.45 |
| P/B ratio | 1.87 | 1.37 |
| EV / EBITDA | 474.34 | N/A |
| FCF yield | 0.22% | N/A |
Profitability
| Metric | ANIK | QSI |
|---|---|---|
| Gross margin | 62.16% | 47.33% |
| Operating margin | -4.24% | -3996.72% |
| Net margin | -3.14% | -6138.26% |
| ROE | -2.76% | -54.67% |
| ROIC | -3.17% | -51.87% |
Growth (annualized)
| Metric | ANIK | QSI |
|---|---|---|
| Revenue CAGR (5Y) | -2.48% | N/A |
| FCF CAGR (5Y) | -39.38% | N/A |
| Total return CAGR (5Y) | -13.40% | -31.06% |
Frequently asked
- How have ANIK and QSI total returns compared?
- Over the past 5 years, ANIK delivered -13.40% and QSI delivered -31.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.